SWOT Analysis Strength: Monoclonal antibody therapeutics have several advantages over conventional drug therapies. They are highly targeted and selective, attacking specific cells or molecular targets involved in disease processes with minimal off-target effects. They also have longer half-lives compared to small molecule drugs or other biologics, requiring less frequent dosing. Lastly,...
0 Commentarios
0 Acciones
1240 Views
0 Vista previa
English
Arabic
Français
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian